Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?

Authors

N. Andruska, Washington University School of Medicine, St. Louis, MO
B.W. Fischer-Valuck, Springfield Memorial Hospital, Springfield, IL
J.A. Efstathiou, Harvard School of Medicine
Z. Smith, Washington University School of Medicine, St. Louis, MO
E. Kim, Washington University School of Medicine, St. Louis, MO
R.J. Brenneman, Washington University School of Medicine, St. Louis, MO
M. Reimers, Washington University School of Medicine, St. Louis, MO
H.A. Gay, Washington University School of Medicine, St. Louis, MO
S.A. Patel, Winship Cancer Institute of Emory University
J.M. Michalski, Washington University School of Medicine, St. Louis, MO
S. Delacroix, LSU Health Sciences Center - New OrleansFollow
B.C. Baumann, Washington University School of Medicine, St. Louis, MO

Document Type

Conference Proceeding

Publication Date

10-22-2022

Publication Title

International Journal of Radiation Oncology, Biology, Physics

Abstract

ASTRO Annual 2022 Meeting

First Page

e203

Volume

114

Issue

3, Supplement 1

Comments

Abstract Number: 2452

Recommended Citation

Andruska, N.; Fischer-Valuck, B.W.; Efstathiou, J.A.; Smith, Z.; Kim, E.; Brenneman, R.J.; Reimers, M.; Gay, H.A.; Patel, S.A.; Michalski, J.M.; Delacroix, S.; and Baumann, B.C., "Does Chemo-Radiotherapy Improve Survival Outcomes vs. Radiotherapy Alone for High-Grade cT1 Urothelial Carcinoma of the Bladder?" (2022). School of Medicine Faculty Publications. 908.
https://digitalscholar.lsuhsc.edu/som_facpubs/908
10.1016/j.ijrobp.2022.07.1126